Shakespeare Wealth Management, Inc. Johnson & Johnson Transaction History

Shakespeare Wealth Management, Inc.

$344 Million
Q2 2024

A detailed history of Shakespeare Wealth Management, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Shakespeare Wealth Management, Inc. holds 3,561 shares of JNJ stock, worth $586,924. This represents 0.15% of its overall portfolio holdings.

Number of Shares

3,561

Previous 3,515 1.31%

Holding current value

$586,924

Previous $556,000 6.47%

% of portfolio

0.15%

Previous 0.16%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$144.38 - $157.78 $6,641 - $7,257	46 Added 1.31%	3,561 $520,000
Q1 2024 May 13, 2024	BUY	$155.22 - $162.74 $9,468 - $9,927	61 Added 1.77%	3,515 $556,000
Q4 2023 Feb 13, 2024	SELL	$145.6 - $158.88 $1,892 - $2,065	-13 Reduced 0.37%	3,454 $541,000
Q3 2023 Nov 13, 2023	BUY	$155.75 - $174.48 $25,387 - $28,440	163 Added 4.93%	3,467 $539,000
Q2 2023 Aug 11, 2023	BUY	$154.35 - $166.11 $1,852 - $1,993	12 Added 0.36%	3,304 $546,000
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $5,969 - $6,642	37 Added 1.14%	3,292 $538,000
Q2 2022 Aug 09, 2022	BUY	$168.19 - $186.01 $8,409 - $9,300	50 Added 1.56%	3,255 $576,000
Q4 2021 Jan 10, 2022	SELL	$155.93 - $173.01 $18,087 - $20,069	-116 Reduced 3.49%	3,205 $548,000
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $20,833 - $23,151	129 Added 4.04%	3,321 $533,000
Q2 2021 Aug 09, 2021	SELL	$159.48 - $171.07 $198,074 - $212,468	-1,242 Reduced 28.01%	3,192 $553,000
Q3 2020 Nov 12, 2020	BUY	$140.38 - $153.83 $154,839 - $169,674	1,103 Added 33.11%	4,434 $660,000
Q1 2020 Apr 01, 2020	SELL	$111.14 - $153.99 $777 - $1,077	-7 Reduced 0.21%	3,331 $437,000
Q4 2019 Feb 10, 2020	SELL	$127.5 - $146.44 $382 - $439	-3 Reduced 0.09%	3,338 $487,000
Q3 2019 Nov 08, 2019	BUY	$126.95 - $142.14 $1,904 - $2,132	15 Added 0.45%	3,341 $432,000
Q2 2019 Aug 12, 2019	SELL	$131.15 - $144.24 $393 - $432	-3 Reduced 0.09%	3,326 $463,000
Q1 2019 May 13, 2019	SELL	$125.72 - $139.79 $377 - $419	-3 Reduced 0.09%	3,329 $465,000
Q4 2018 Feb 04, 2019	SELL	$122.84 - $147.84 $1,474 - $1,774	-12 Reduced 0.36%	3,332 $430,000
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $1,094 - $1,285	9 Added 0.27%	3,344 $462,000
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $597 - $658	-5 Reduced 0.15%	3,335 $405,000
Q1 2018 Aug 14, 2018	BUY	$125.1 - $148.14 $417,834 - $494,787	3,340 New	3,340 $428,000

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shakespeare Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Shakespeare Wealth Management, Inc. with notifications on news.

Account

Shakespeare Wealth Management, Inc. Johnson & Johnson Transaction History